Skip to main content
PLOS One logoLink to PLOS One
. 2020 Aug 7;15(8):e0237343. doi: 10.1371/journal.pone.0237343

The Mont Blanc Study: The effect of altitude on intra ocular pressure and central corneal thickness

Carlo Bruttini 1, Alice Verticchio Vercellin 1,2,3, Catherine Klersy 4, Annalisa De Silvestri 4, Carmine Tinelli 4, Ivano Riva 2, Francesco Oddone 2, Andreas Katsanos 5, Luciano Quaranta 1,*
Editor: Sanjoy Bhattacharya6
PMCID: PMC7413504  PMID: 32764811

Abstract

The aim of the Mont Blanc Study was to investigate the relationship between intraocular pressure (IOP), central corneal thickness (CCT), and altitude in healthy subjects. Thirty-three eyes of 33 healthy volunteers (mean age: 24.8 years, 17 females) had their IOP measured with Perkins and I-Care tonometers and their CCT using ultrasound pachymetry at three locations in Italy with different altitudes: Pavia, (PV), 77 meters above sea level (a.s.l); Courmayeur (CM), 1300 meters a.s.l; Pointe Helbronner (PH), 3466 meters a.s.l.). The measurements were performed at 9 am, 11 am, 1 pm and 3 pm (±30’) in indoor settings (mean temperature of 19°C) in PV and PH. At 9 am, CCT and IOP were measured outdoor (mean temperature of -1.4°C) at PH. The mean values of the IOP curve decreased from PV to PH with the Perkins (p = 0.02) and I-Care tonometers (p = 0.001). Instead, CCT increased upon ascension from PV to PH (p = 0.01), and from CM to PH (p = 0.002). When exposed to sub-zero temperature, the IOP increased (p<0.001), while the CCT did not change (p = 0.30). The results suggest that IOP significantly decreased and CCT significantly increased upon ascension from the sea level to higher altitudes.

Introduction

The increasing popularity of recreational activities such as mountain trekking and skiing has raised interest in the effects that hypoxic and hypobaric conditions have on the human body. In particular, intraocular pressure (IOP) changes are clinically important for glaucomatous patients and persons at higher risk of developing glaucoma, because IOP is a key risk factor for glaucoma onset and progression. [1]

Previous studies that investigated the relationship between IOP and altitude produced contrasting results. While several papers have shown that IOP increases with increasing altitude, [2, 3] others have suggested an inverse correlation between IOP and altitude. [47] These conflicting results may be due to several methodological issues that could have influenced the recordings at different altitudes, e.g. the physical effort performed by the subjects to reach higher altitudes, [2, 6, 7] the fact that central corneal thickness (CCT) measurements may have affect the measured IOP values, [35] and different temperature conditions in which IOP was measured. [5]

The aim of the ‘Mont Blanc Study’ was to evaluate the relationship between altitude and IOP, measured with two different tonometers, and CCT. The systemic parameters (arterial blood pressure, BP, heart rate, HR, arterial oxygen saturation, SaO2) were also assessed.

Materials and methods

The Mont Blanc Study was a prospective, observational cohort study. The Ethics Committee of the Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, approved the procedure in accordance with the 1964 Declaration of Helsinki. Subjects were asked to fill out a general health questionnaire and to sign an informed consent form.

Thirty-three healthy volunteers (mean age: 24.8 ± 3.3, 17 female) were recruited. Exclusion criteria were: any type of systemic and/or ocular disease; positive family history for glaucoma; arterial BP>140/90 mmHg measured during the enrollment visit; any systemic medication that could influence IOP and BP values. The test eye was determined based on the inclusion and exclusion criteria. For each study participant, if both eyes qualified, one eye was randomly assigned as the observational study eye, and the same eye was utilized throughout the study. All subjects were asked to abstain from coffee and alcoholic beverages at least in the 12 hours before measurements. Smokers were asked not to smoke at least in the 30 minutes before measurements. [8, 9].

The subjects enrolled in the study did not perform any physical effort nor underwent any acclimatization process, and measurements of CCT and IOP were assessed and collected at the same time point and in the same environmental temperature.

In the present study IOP was measured in healthy volunteers at 77 m above sea level (a.s.l.) (Pavia, PV, Italy), at 1,300 m a.s.l. (Courmayeur, CM, Italy) and 3,466 m a.s.l. (Pointe Helbronner, PH, Mont Blanc Mountain, Italy). The ascent from CM was performed via a high-speed cableway, which took 15 minutes to reach PH. IOP and CCT, and the aforementioned systemic parameters, were measured in closed environment at constant temperature at the three different altitudes (IN conditions). IOP and CCT were also measured in the open air at PH (OUT conditions), in order to investigate the effect of cold on these parameters.

Enrollment visit

The medical examination at the enrollment visit was performed in PV and consisted of a complete ophthalmic examination that included: determination of axial length (AL) and corneal curvature assessed by optical biometry (IOLMaster 500, Carl Zeiss Meditec AG, Germany); and evaluation of the optic nerve head (ONH) parameters and retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) thickness assessed by spectral domain optical coherence tomography (iVue SD-OCT system, Optovue, Inc., Fremont, CA). CCT was assessed by ultrasound pachymetry (PachMATE2) and IOP by both applanation tonometry (Perkins MK2, Clement and Clarke) and rebound tonometry (I-Care TAO1i tonometer, Icare Finland Oy), under topical anaesthesia with Oxybuprocaine drops. A tonometric curve has been carried out with four IOP measurements at 9 am (± 30 min), 11 am (± 30 min), 1 pm (± 30 min) and 3 pm (± 30 min). At 9 am BP, HR and SaO2 were also recorded. All parameters were measured with the subject seated for at least 5 minutes.

SkyWay data collection

Measurements of CCT, IOP, BP, HR and SaO2 of the eligible subjects were assessed at 9 am (± 30 min) in the indoor environment of the CM Station (mean temperature: 19°C). These measurements, along with the IOP curve, were repeated at PH, which was reached by the ‘Skyway Mont Blanc cable car’ in 15 minutes. In addition, environmental temperature, atmospheric pressure, and humidity were also measured at PH. CCT and IOP were also assessed in the open air in a sub-zero temperature (-1.4°C) at PH at 9.00 am (± 30 min).

Statistical analysis

Quantitative variables were normally distributed (Shapiro test) and were described as Mean and Standard Deviation (SD); qualitative variables were summarized using count and percentages, while differences were analysed using the chi square test. For quantitative variables, comparisons between two groups were carried out with the t-test for independent observations, while analysis of variance (ANOVA) with Bonferroni-adjusted p values was used to compare continuous variables among more than two groups.

To take in account different factors that could affect the association between IOP and altitude, multilevel mixed models were fitted using IOP as dependent variables, place (PV or PH) and time as independent variables in the fixed part of the models, and patients as random factors. Models were then adjusted for CCT. Adjusted differences and 95% confidence intervals (95%CI) were computed. Interaction of altitude and time of the day to assess whether the time of the day influenced the difference was tested and excluded.

Post hoc comparisons were also performed at each time point (Bonferroni correction). P<0.05 was considered statistically significant. All tests were two-sided. Data analysis was performed using the STATA statistical package (release 14.1, 2015, Stata Corporation, College Station, Texas, USA).

Results

One eye from each of 33 healthy volunteers (mean age: 24.8 ± 3.3 years, 17 females) was considered in the analysis. The measured parameters (RNFL and GCC thickness, ONH parameters) were within normal limits for all subjects (detailed results not shown). The mean AL was 23.58 mm [SD: 0.68]. Tonometric measures are summarized in Table 1.

Table 1. Comparison of Intraocular Pressure (IOP) (mean values ± standard deviation, SD) measured in mmHg at four time point (9 am (± 30 min), 11 am (± 30 min), 1 pm (± 30 min) and 3 pm (± 30 min)).

Hour Pavia1 mean (SD) Courmayeur2 mean (SD) Pointe Helbronner3 mean (SD) Adjusted mean difference (95%CI)* p-value (Bonferroni)
Perkins
9 11.94(±2.47) 11.36(±3.53) 11.58(±2.72) 2vs1–0.80 (-2.10 to 0.50) 0.418
11 11.03(±2.36) 10.79(±2.63) 3vs1–0.82 (-1.54 to -0.10) 0.020
13 11.27(±2.67) 10.00(±3.21) 3vs2–0.02 (-1.32 to 1.29) 1.000
15 10.88(±2.47) 9.48(±2.86)
I-Care
9 15.27(±3.38) 13.80(±3.10) 14.61(±2.94) 2vs1–1.58 (-2.69 to -0.48) 0.002
11 14.44(±3.42) 13.53(±3.39) 3vs1–0.89 (-1.51 to -0.28) 0.001
13 14.39(±3.39) 13.56(±3.46) 3vs2 0.69 (-0.41 to 1.79) 0.403
15 14.61(±4.01) 13.44(±2.91)

The IOP recordings were assessed by Perkins and I-Care tonometers. The measurements were obtained at different altitudes: at 77 m a.s.l. (Pavia, 1), at 1,300 m a.s.l. (Courmayeur, 2) and at 3,466 m a.s.l. (Pointe Helbronner, 3).

*adjusted for time of the day & central corneal thickness.

Effect of altitude on IOP

Altitude was significantly associated with differences in the IOP measures (Perkins p = 0.19, I-Care p<0.001), while accounting for the time of the day and CCT in a mixed regression model.

As shown in Table 1, the mean IOP values decreased significantly and similarly from PV to PH with both Perkins (p = 0.020) and I-Care (p = 0.001) tonometers. Also, IOP was shown to decrease from PV to CM with both instruments, though only measures performed with the I-Care instrument retained statistical significance (p = 0.002); finally, no significant difference was observed for changes from CM to HB with any of the two instruments.

Tonometric values decreased over the time of the day both with the Perkins (p = 0.002) and the I-Care (p = 0.016) instruments (Table 1).

However, the time of the day did not modify the size of the difference between altitudes tonometric measures (Perkins, p for interaction = 0.39 and I-Care, p for interaction = 0.91).

Central corneal thickness upon ascension

CCT increased upon ascension from PV to PH (PV vs PH, Mean [SD]: 559.45 μm [25.35] vs 563.22 μm [26.05]; p = 0.01, Fig 1). An increase in CCT was also found between CM and PH (CM vs PH, 558.86 μm [24.20] vs 563.22 μm [6.05]; p = 0.002). No significant difference was found between PV and CM (PV vs CM, 559.45 μm [25.35] vs 558.86 μm [24.20]; p = 0.62).

Fig 1. Central corneal thickness at three different altitudes.

Fig 1

Changes of central corneal thickness measured in μm upon ascension from Pavia (PV, black bar), to Courmayeur (CM, dark grey bar), and Pointe Helbronner (PH, light grey bar). CCT increased in PH with respect to both PV and CM. *P-value indicates a statistically significant difference (p<0.05).

Effect of a sub-zero environmental temperature on IOP and CCT

When exposed to a sub-zero temperature, the IOP increased (IN vs OUT, Mean [SD]: 14.29 mmHg [2.2] vs 16.98 mmHg [3.71]; p<0.001, Fig 2A), while CCT was similar in the two conditions (IN vs OUT, 563.22 μm [26.05] vs 565.20 μm [27.21]; p = 0.30, Fig 2B).

Fig 2. Effect of sub-zero temperature on intra ocular pressure and central corneal thickness.

Fig 2

Comparison of intraocular pressure and central corneal thickness at Pointe Helbronner (3,466 m above sea level) measured in a closed environment (19°C) and in the open air (-1°C). Outside values are represented with black bars and inside values are represented with light grey bars. Statistics found no difference in CCT, but a significant effect of cold on IOP. *P-value indicates a statistically significant difference (p<0.05).

Correlation between IOP and systemic parameters

Clinical parameters of diastolic BP (DBP), systolic BP (SBP) and HR significantly increased, and arterial oxygen saturation (SaO2) significantly decreased at high altitudes compared to sea level. An overview of all clinical data is shown in Table 2.

Table 2. Mean diastolic and systolic blood pressure, heart rate and arterial oxygen saturation at three altitudes.

DBP (mmHg) SBP (mmHg) HR (beats/min) SaO2(%)
PH 77.8±7.6 122.7±7.6 79.3±9.9 88.2±2
CM 79±7.1 126.9±8.9 75.7±11.6 96.8±1.4
PV 67.5±5.5 115.9±7.4 68.6±8.4 99

Mean values (±standard deviation, SD) of systemic parameters measured at three different altitudes: PH (3,466 m a.s.l., Pointe Helbronner), CM (1,300 m a.s.l., Courmayeur) and PV (77 m a.s.l. Pavia). DBP, diastolic blood pressure; HR, heart rate; SaO2, arterial oxygen saturation; SBP, systolic blood pressure.

A significant IOP increase of 0.8 mmHg (Perkins) or 0.6 mmHg (I-Care) along a 10 mmHg increase of DBP was observed from PV to PH (p<0.001 and p = 0.018 respectively). Moreover, a direct relationship was found between IOP and SaO2, with an increase of 0.12 mmHg (Perkins) or 0.30 mmHg (I-Care) for each unit of percentage of SaO2 (p = 0.050 and p = 0.006 respectively). Present results also showed an IOP reduction of -0.3 mmHg (Perkins) and -0.5 mmHg (I-Care) for 10 bpm increase in HR (p = 0.050 and p = 0.038 respectively).

Discussion

The Mont Blanc Study was conducted in order to evaluate the relationship between IOP, CCT and systemic circulatory parameters (SBP, DBP, SaO2) in a group of healthy subjects at different altitudes. The present data showed an inverse correlation between IOP and altitude: the mean values of the tonometric curve decreased at PH compared to PV. The decrease in IOP with high altitude corresponded to a decrease in DBP and SaO2. The reduction in IOP was mirrored by an increase of CCT upon ascension from PV to PH.

Effect of altitude on IOP and CCT

The diurnal curves recorded at different altitudes (PV and PH, Table 1) showed the highest IOP values at 9 am both with Perkins and I-Care, in accordance with previous literature. [1012] Upon ascension from the sea level to high altitudes, the mean values of the tonometric curve significantly decreased. Present results were obtained overcoming the limitations of the previous studies investigating the relationship between IOP, CCT and altitude. In details, the studied subjects did not perform any physical effort, nor underwent any acclimatization process, and IOP and CCT measurements were assessed at the same time of the day at different altitudes and with the same environmental temperature. The magnitude of IOP changes at high altitude found in the present paper is in accordance with previous literature. [2, 3, 13, 14] The approximately one mmHg of IOP decreased at high altitude could be considered relatively small. However, taking into account that each millimetre of mercury of IOP elevation might increase by about 20% the risk of developing glaucoma, [1, 13] while each mmHg of IOP reduction may decrease the risk of glaucoma progression by about 10%, [15] the IOP changes induced by altitude can have clinical significance. Concerning the physiological mechanisms causing the IOP reduction at PH, it could be hypothesized that a relationship between IOP and hypoxic conditions exists; depleted oxygen supply to the non-pigmented ciliary epithelium and hence to decreased aqueous humor production induce a decline in IOP at high altitudes, where systemic hypoxia occurs. [4] Indeed, part of the aqueous humor production depends on a unidirectional transport system of solutes, passively followed by water through osmosis. [16] In details, the carbonic anhydrase catalyzes the rapid conversion of carbon dioxide and water to bicarbonate and protons (CO2 + H2O -> H2CO3 -> H + HCO3). Hydrogen ion is exchanged for sodium, which is expelled through sodium/potassium phosphatase. The high concentration of sodium and bicarbonate in the intercellular spaces leads to the shift in the posterior chamber of water by osmosis. The human body reacts to hypoxia with adaptive measures, among which the increase in respiratory depth. The hyperventilation decreases the carbonic acid (H2CO3) production, by producing a decrease in CO2. As a consequence, H+ concentration is reduced in the posterior chamber, leading to a decrease of the osmotic gradient between capillaries in the ciliary body and the posterior chamber. Therefore, we can speculate that this mechanism induced the decrease in aqueous humor production and of IOP at high altitudes. [17] It is important to highlight that both the Perkins and I-care tonometers showed a decrease of IOP values at high altitude in the study subjects. However, the I-Care tonometer is known to overestimates IOP compared to the Perkins, [18] thus the difference between the IOP measurements assessed by the two instruments at each time point.

An increase of CCT was recorded at PH compared to PV, in accordance with previous literature. [24, 7] The hypoxic conditions found at high altitude might hinder corneal endothelial function, thus inducing corneal edema and therefore an increase of CCT. [2]

Effect of low environmental temperature on IOP and CCT

With cold, IOP increased (p<0.001) while CCT did not undergo any significant change. Ortiz et al. [19] evaluated the effect of a stream of cold air (-19°C) directed toward a closed eye. After 40 minutes of exposure to continuous stream of cold air a decrease of IOP was found. The different results obtained in the present paper may be explained by the fact that the effects of low environmental temperature at PH influence the whole body, and was not directed only toward the eye. Indeed, cold is known to induce a sympathetic drive, [20] with an increase of norepinephrine release that rises the IOP. [21]

Correlation between IOP and systemic parameters

The recorded levels of SaO2 were lower at PH when compared to both PV and CM, in accordance with literature. [22] The decrease in SaO2 is explained by the fall of partial pressure of oxygen in the breathing air at high altitudes. Although the percentage of oxygen in inhaled air is constant at different altitudes, the fall in atmospheric pressure at higher altitudes decreases the partial pressure of inhaled oxygen and hence the driving pressure for gas exchange in the lungs. SBP, DBP and HR increased in CM and at PH compared to PV. These findings are in line with the existing literature. [20, 2326] The rise in BP upon ascension is due to the effect of oxygen deprivation in increasing the activity of the sympathetic nervous system. [24] HR increases as an adaptive measure to the fall in partial pressure of oxygen at high altitude in order to keep up with oxygen delivery to the tissues. [27]

A direct relationship was found when comparing DBP and IOP, in accordance with previous papers. [28, 29] Moreover, the present study also showed a direct relationship between IOP and SaO2, in accordance with Pavlidis et al., 2006 [6] and Bosch et al., 2010 [4]. On the contrary, Nazari et al., 2013 [5] did not find any correlation between these two parameters. These differences can be explained by methodological differences as well as dissimilarities in environmental conditions in which these studies were performed.

Limitations of the study

The Mont Blanc study has certain limitations. The first one is that the tonometers used in the study have not been validated for use at high altitudes. Nonetheless, other studies carried out at comparable altitudes have utilized the same instruments. Further studies to validate the use of such instruments at high altitude are indeed required. A second limitation is the lack of data on the acclimatization process: it would be important to assess the influence of acclimatization on IOP and CCT measurements in healthy volunteers. Thirdly, the Mont Blanc study volunteers were healthy subjects with a mean age of 24.8 years. Glaucomatous subjects are older and the pathophysiological mechanism underlying their condition may affect IOP and CCT at high altitude differently compared to healthy subjects.

Conclusions

The Mont Blanc study showed that IOP decreases and CCT increases upon ascension at high altitudes The Mont Blanc study findings suggest that high altitude, decreasing the IOP, might represent a protective factor for the glaucomatous patients. In order to test this hypothesis and its clinical relevance, further studies are needed in order to investigate the influence of altitude in a glaucomatous population and the effect of acclimatization on IOP and CCT.

Supporting information

S1 Dataset

(XLS)

Acknowledgments

The authors would like to thank the Skyway Monte Bianco (Funivie Monte Bianco S.p.a, Aosta Valley, Italy), the Regione Valle d’Aosta, and all the volunteers who participated in the study. The authors would like to thanks for their contribution Drs. Beatrice Montanaro, Massimiliano Manera and Giovanni Milano.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work. The contribution of the author Dr. Alice C. Verticchio Vercellin and Dr. Ivano Riva was supported by Fondazione Roma and by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Gordon M, Beiser J, Brandt J, Heuer DK, Higginbotham EJ, Johnson CA, et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120:714–20. 10.1001/archopht.120.6.714 [DOI] [PubMed] [Google Scholar]
  • 2.Karakucuk S, Mujdeci M, Baskol G, Arda H, Gumus K, Oner A. Changes in central corneal thickness, intraocular pressure, and oxidation/antioxidation parameters at high altitude. Aviat Space Environ Med. 2010; 83:1044–48. [DOI] [PubMed] [Google Scholar]
  • 3.Somner J, Morris D, Scott K, MacCormick IJC, Aspinall P, Dhillon B. What happens to Intraocular Pressure at High Altitude? Invest Ophthalmol Vis Sci. 2007; 48:1622–6 10.1167/iovs.06-1238 [DOI] [PubMed] [Google Scholar]
  • 4.Bosch M, Barthelmes D, Merz T, Truffer F, Knecht PB, Petrig B. Intraocular Pressure during a very high altitude climb. Invest Ophthalmol Vis Sci. 2010; 51:1609–13. 10.1167/iovs.09-4306 [DOI] [PubMed] [Google Scholar]
  • 5.Nazari H, Nilforushan N, Sedaghat A, Soudi R, Irani A, Gordiz A. Intraocular pressure after exposure to moderate altitude. Graefes Arch Clin Exp Ophthalmol 2013; 251:123–27. 10.1007/s00417-012-2050-4 [DOI] [PubMed] [Google Scholar]
  • 6.Pavlidis M, Stupp T, Georgalas I, Georgiadou E, Moschos M, Thanos S. Intraocular pressure changes during high altitude acclimatization. Graefe Arch Clin Expo Ophthalmol. 2006; 244:298–304. [DOI] [PubMed] [Google Scholar]
  • 7.Willmann G, Schommer K, Schultheiss M, Fischer MD, Bartz-Schmidt KU, Gekeler F, et al. Effect of high altitude exposure on intraocular pressure using Goldmann application tonometry. High Alt Med Biol. 2017; 18:114–120. 10.1089/ham.2016.0115 [DOI] [PubMed] [Google Scholar]
  • 8.Jiwani A, Rhee D, Brauner S, Gardiner MF, Chen TC, Shen LQ, et al. Effects of caffeinated coffee consumption on intraocular pressure, ocular perfusion pressure, and ocular pulse amplitude: a randomized controlled trial. Eye (Lond). 2012; 26:1122–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wang S, Wang J, Wong T. Alcohol and eye diseases. Surv Ophthalmol. 2008; 53:512–25. 10.1016/j.survophthal.2008.06.003 [DOI] [PubMed] [Google Scholar]
  • 10.Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, et al. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Invest Ophthalmol Vis Sci. 2006; 47:2917–23. 10.1167/iovs.05-1253 [DOI] [PubMed] [Google Scholar]
  • 11.Konstas AG, Kahook MY, Araie M, Katsanos A, Quaranta L, Rossetti L, et al. Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment. Adv Ther. 2018; 35:1775–1804. 10.1007/s12325-018-0812-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Quaranta L, Katsanos A, Russo A, Riva I. 24-hour intraocular pressure and ocular perfusion pressure in glaucoma. Surv Ophthalmol. 2013; 58(1):26–41 10.1016/j.survophthal.2012.05.003 [DOI] [PubMed] [Google Scholar]
  • 13.Medeiros F, Wienreb R, Zangwill L, Alencar LM, Sample PA, Vasile C, et al. Long-term intraocular pressure and risk of conversion from ocular hypertension to glaucoma. Ophthalmology. 2008; 115:934–40. 10.1016/j.ophtha.2007.08.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Siaudvytyte L, Januleviciene I, Daveckaite A, Ragauskas A, Bartusis L, Kucinoviene J, et al. Literature review and meta-analysis of translaminar pressure difference in open-angle glaucoma. Eye (Lond). 2015; 29:1242–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Heijl A, Leske M, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120:1268–79. 10.1001/archopht.120.10.1268 [DOI] [PubMed] [Google Scholar]
  • 16.Kiel J, Hollingsworth M, Rao R, Chen M, Reitsamer HA. Ciliary blood flow and aqueous humor production. Prog Retin Eye Res. 2011; 30:1–17. 10.1016/j.preteyeres.2010.08.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.McArdle W, Katch F, Katch V. Exercise Physiology: Energy, Nutrition and Human Performance. Lippincott Williams & Wilkins; sixth ed 2006. [Google Scholar]
  • 18.Ting SL, Lim LT, Ooi CY, Rahman MM. Comparison of Icare Rebound Tonometer and Perkins Applanation Tonometer in Community Eye Screening. Asia Pac J Ophthalmol. 2019;8:229‐232. [DOI] [PubMed] [Google Scholar]
  • 19.Ortiz G, Cook D, Yablonski M, Masonson H, Harmon G. Effect of cold air in aqueous humor dynamics in humans. Invest Ophthalmol Vis Sci. 1988; 29:138–40 [PubMed] [Google Scholar]
  • 20.Richalet J, Letournel M, Souberbielle J. Effects of high-altitude hypoxia on the hormonal response to hypothalamic factors. Am J Physiol Regul Integr Comp Physiol. 2010; 299:1685–92. [DOI] [PubMed] [Google Scholar]
  • 21.Waitzman M, Woods W, Cheek W. Effects of prostaglandins and norepinephrine on ocular pressure and pupil size in rabbits following bilateral cervical ganglionectomy. Invest Ophthalmol Vis Sci. 1979; 18:52–60. [PubMed] [Google Scholar]
  • 22.Pescosolido N, Barbato A, Di Blasio D. Hypobaric hypoxia: effects on contrast sensitivity in high altitude environments. Aerosp Med Hum Perform. 2015; 86:118–24. 10.3357/AMHP.3938.2015 [DOI] [PubMed] [Google Scholar]
  • 23.Casey D, Braith R, Pierce G. Changes in central artery blood pressure and wave reflection during a cold pressor test in young adults. Eur J Appl Physiol. 2008; 103:539–43. 10.1007/s00421-008-0746-2 [DOI] [PubMed] [Google Scholar]
  • 24.Hansen J, Sander M. Sympathetic neural over activity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol. 2003; 546:921–29. 10.1113/jphysiol.2002.031765 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Naeije R, Mèlot C, Mols P, Hallemans R. Effects of vasodilators on hypoxic pulmonary vasoconstriction in normal man. Chest. 1982; 82,404–10. 10.1378/chest.82.4.404 [DOI] [PubMed] [Google Scholar]
  • 26.Winslow R. The role of hemoglobin oxygen affinity in oxygen transport at high altitude. Respir Physiol Neurobiol. 2007; 158,121–27. 10.1016/j.resp.2007.03.011 [DOI] [PubMed] [Google Scholar]
  • 27.Boussuges A, Molenat F, Burnet H, Cauchy E, Gardette B, Sainty JM, et al. Operation Everest III (Comex '97): modifications of cardiac function secondary to altitude-induced hypoxia. An echocardiographic and Doppler study. Am J Respir Crit Care Med. 2000; 161:264–70. 10.1164/ajrccm.161.1.9902096 [DOI] [PubMed] [Google Scholar]
  • 28.Cymerman A, Rock P, Muza S, Lyons TP, Fulco CS, Mazzeo RS, et al. Intraocular pressure and acclimatization to 4300 M altitude. Aviat Space Environ Med. 2000; 71:1045–50. [PubMed] [Google Scholar]
  • 29.Cushing T, Paterson R, Haukoos J, Harris NS. Intraocular pressure is not associated with acute mountain sickness. High Alt Med Biol. 2013; 14,342–45. 10.1089/ham.2013.1024 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Sanjoy Bhattacharya

4 May 2020

PONE-D-20-07934

The Mont Blanc Study: the effect of Altitude on Intra Ocular Pressure and Central Corneal Thickness

PLOS ONE

Dear Dr. Quaranta,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Both learned reviewers have offered criticisms of the manuscript. However, a reviewer have pointed out potential inclusion of data and several questions that need to be carefully addressed by making appropriate revisions. 

We would appreciate receiving your revised manuscript by Jun 18 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Sanjoy Bhattacharya

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1.    Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: As you suggest acclimatization may play a role. The length of time subjects were in each environment prior to testing should be noted. How was the test eye determined ? You need to state that the same eye was utilized throughout the study. A comparison of the length of time at each environment with real life time of exposures and potential effects should be included.

Reviewer #2: This is an interesting study. Published reports comparing IOP and altitude have shown contrasting results. The authors of this study found an inverse correlation between altitude and IOP, while CCT correlated with ascension from sea level. There are a few issues that I have with the data as presented.

The following are some comments and questions:

1.) In figure one there I cannot see a line for Courmayeur. There is only a triangle shown at the 9:00 am mark.

2.) Table 2 header says I-Care tonometer was used, while the figure legend says Perkins was used.

3.) Where are the mean values coming from detailed in the paragraph starting at line 125? Is this mean across all time points? If so, that is not seeming to match up with the table. Please add a separate column in the table detailing the means from this specific analysis that was discussed in the aforementioned paragraph. Also, was the mean value used in that calculation from all time points? If so, did authors measure the value of these 33 volunteers 4 separate times, then average that? Or did they average each individual across all time points?

4.) The authors mention in the introduction that CCT may have an effect on IOP values (line 33-34). However, in the work they did not explore this further. The authors should examine the IOP across different attitudes while controlling for CCT values. They already have this data so it should not be difficult.

5.) One central issue that needs to be discussed is why the large discrepancy between the tonometers between PH and PV in Tables 1 and 2. We see significant differences with I-Care at three time points, yet only one significant difference with Perkins (3pm). Which table are we to believe? We see only a common significant change at 3 pm. This should be discussed further.

6.) Following from point 5. There seems to be significant changes across time points. Since authors are presenting this data, that needs to be discussed further. What influence does time have on IOP measurements at these varying elevations.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 7;15(8):e0237343. doi: 10.1371/journal.pone.0237343.r002

Author response to Decision Letter 0


24 Jun 2020

We would like to thank the editor and reviewers of PLOS One for your indications. Based on the comments we have edited the manuscript as outlined below:

Review Comments to the Author:

Reviewer #1: As you suggest acclimatization may play a role. The length of time subjects were in each environment prior to testing should be noted. How was the test eye determined ? You need to state that the same eye was utilized throughout the study. A comparison of the length of time at each environment with real life time of exposures and potential effects should be included.

We thank the reviewer for the comments. The test eye was determined based on the inclusion and exclusion criteria. For each study participant, if both eyes qualified, one eye was randomly assigned as the observational study eye, and the same eye was utilized throughout the study. The measurements were taken on two different days, one day in Pavia and one day on the Mont Blanc. The study measurements were taken in Pavia at four different time points (at 9 am (± 30 min), 11 am (± 30 min), 1 pm (± 30 min) and 3 pm (± 30 min)), and the subjects spent the time from 9 am (± 30 min) to 3 pm (± 30 min) in the indoor hospital settings of the University Eye Clinic of Pavia. The second day of the study experiment took place at the Skyway Mount Blanc. In details, the subjects underwent the measurement at 9 am (± 30 min) in the indoor settings of the Courmayeur Station (mean temperature: 19°C). Immediately after, the subject took the ‘Skyway Mont Blanc cable car’ and they reached in 15 minutes the Pointe Helbronner Station, where the measurements were repeated at the same time points evaluated in Pavia (at 9 am (± 30 min), 11 am (± 30 min), 1 pm (± 30 min) and 3 pm (± 30 min)). When the subjects reached the Pointe Helbronner Station, the measurement of the first time point (9 am (± 30 min)) was taken both indoor and in the open air in a sub-zero temperature; immediately after the outdoor measurement all the subjects went back indoor, and they spent the time from 9 am (± 30 min) to 3 pm (± 30 min) in the indoor settings of the Pointe Helbronner Station. Since at least 1 to 3 days are required for the body to undergo the physiological changes characteristics of the acclimatization process, further studies are needed to evaluate this aspect, that was beyond the purpose of our study, as highlighted in the “limitations of the study” section of the manuscript. We edited the revised manuscript to clarify the methods per your comments, thank you.

Reviewer #2: This is an interesting study. Published reports comparing IOP and altitude have shown contrasting results. The authors of this study found an inverse correlation between altitude and IOP, while CCT correlated with ascension from sea level. There are a few issues that I have with the data as presented.

The following are some comments and questions:

1.) In figure one there I cannot see a line for Courmayeur. There is only a triangle shown at the 9:00 am mark.

We thank the reviewer for the indication. The Reviewer is right. There is only one measurement in Courmayeur at 9 am; Figure 1 has been removed in the revised manuscript, these data are now detailed in Table 1.

2.) Table 2 header says I-Care tonometer was used, while the figure legend says Perkins was used.

Thank you for the comment. In the revised manuscript, Table 2 has been removed. We added a comparison of IOP values assessed by both Perkins and I-Care tonometers in Table 1.

3.) Where are the mean values coming from detailed in the paragraph starting at line 125? Is this mean across all time points? If so, that is not seeming to match up with the table. Please add a separate column in the table detailing the means from this specific analysis that was discussed in the aforementioned paragraph. Also, was the mean value used in that calculation from all time points? If so, did authors measure the value of these 33 volunteers 4 separate times, then average that? Or did they average each individual across all time points?

We thank the Reviewer for this comment. We amended the analysis in the revised manuscript in order to address the Reviewer concerns and we have adjusted for CCT. We added these data in Table 1 of the revised manuscript.

4.) The authors mention in the introduction that CCT may have an effect on IOP values (line 33-34). However, in the work they did not explore this further. The authors should examine the IOP across different attitudes while controlling for CCT values. They already have this data so it should not be difficult.

The multilevel mixed models was adjusted for CCT. This new analysis has been introduced in the revised MS per your comment, thank you.

5.) One central issue that needs to be discussed is why the large discrepancy between the tonometers between PH and PV in Tables 1 and 2. We see significant differences with I-Care at three time points, yet only one significant difference with Perkins (3pm). Which table are we to believe? We see only a common significant change at 3 pm. This should be discussed further.

We thank the reviewer for the comment. In the revised manuscript, a new statistical analysis was performed, and we included the new data in the “results” section and Table 1 of the revised manuscript. As shown in Table 1 of the revised manuscript, the mean IOP values decreased significantly and similarly from Pavia to Pointe Helbronner with both the Perkins (p=0.020) and the I-Care (p=0.001) tonometers. Also, IOP was shown to decrease from Pavia to Courmayeur with both instruments, though only measures performed with the I-Care instrument retained statistical significance (p=0.002); finally, no significant difference was observed for changes from Courmayeur to Pointe Helbronner with any of the two instruments. Tonometric values decreased over the time of the day both with the Perkins (p=0.002) and the I-Care (p=0.016) instruments (Table 1). Perkins tonometer is considered the ‘gold standard’ in handheld applanation tonometers, as the IOP measurements have been shown to be comparable to those of Goldmann applanation tonometer. On the other hand, the IOP measurements assessed by I-Care have shown a good repeatability, and this type of tonometer is used widely for its several advantages, such as the fact that it does not require the use of anesthetic eye drops and fluorescein dye, and it measures the IOP with reduced discomfort for the subjects. It is important to highlight that I-Care tonometer is known to overestimates IOP compared to the Perkins (Ting SL, Lim LT, Ooi CY, Rahman MM. Comparison of Icare Rebound Tonometer and Perkins Applanation Tonometer in Community Eye Screening. Asia Pac J Ophthalmol (Phila). 2019;8(3):229‐232. doi:10.22608/APO.2018433), thus the difference between the IOP measurements assessed by the two instruments at each time point. Importantly, both the Perkins and I-Care tonometers showed a decrease of IOP values at high altitude in the study subjects, thus suggesting the potential use of both of them in settings where the need of a handheld tonometer is required. The revised manuscript has been edited per your comments, thank you.

6.) Following from point 5. There seems to be significant changes across time points. Since authors are presenting this data, that needs to be discussed further. What influence does time have on IOP measurements at these varying elevations.

Both the differences between altitudes and the differences between time of the day were explored while adjusting for CCT. This is now better detailed in Table 1 and in the text of the revised manuscript. Thank you for the comment.

Attachment

Submitted filename: Authors response to Reviewers.docx

Decision Letter 1

Sanjoy Bhattacharya

24 Jul 2020

The Mont Blanc Study: the effect of Altitude on Intra Ocular Pressure and Central Corneal Thickness

PONE-D-20-07934R1

Dear Dr. Quaranta,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sanjoy Bhattacharya

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: Authors have adequately addressed concerns of this reviewer. I believe that this article should be published by PLOS one.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Sanjoy Bhattacharya

29 Jul 2020

PONE-D-20-07934R1

The Mont Blanc Study: the effect of Altitude on Intra Ocular Pressure and Central Corneal Thickness

Dear Dr. Quaranta:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sanjoy Bhattacharya

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Dataset

    (XLS)

    Attachment

    Submitted filename: Authors response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES